Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer
- PMID: 19697322
- DOI: 10.1002/ijc.24847
Tristetraprolin regulates expression of VEGF and tumorigenesis in human colon cancer
Abstract
Tristetraprolin (TTP) is an AU-rich element-binding protein that regulates mRNA stability. Here, we report that TTP suppress the growth of human colon cancer cells both in vivo and in vitro by regulating of the expression of vascular endothelial growth factor (VEGF). TTP protein expression in human colonic tissues was markedly decreased in colonic adenocarcinoma compared with in normal mucosa and adenoma. VEGF expression was higher in colonic adenocarcinoma than in normal mucosa and adenoma. Specific inhibition of TTP expression by RNA-interference increased the expression of VEGF in cultured human colon cancer cells, and TTP overexpression markedly decreased it. In addition, elevated expression of TTP decreased the expression level of luciferase linked to a 3' terminal AU-rich element (ARE) of VEGF mRNA. Colo320/TTP cells overexpressing TTP grew slowly in vitro and became tumors small in size when xenografted s.c into nude mice. These findings demonstrate that TTP acts as a negative regulator of VEGF gene expression in colon cancer cells, suggesting that it can be used as novel therapeutic agent to treat colon cancer.
Similar articles
-
Roles of Tristetraprolin in Tumorigenesis.Int J Mol Sci. 2018 Oct 29;19(11):3384. doi: 10.3390/ijms19113384. Int J Mol Sci. 2018. PMID: 30380668 Free PMC article. Review.
-
The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.Gastroenterology. 2009 May;136(5):1669-79. doi: 10.1053/j.gastro.2009.01.010. Epub 2009 Jan 15. Gastroenterology. 2009. PMID: 19208339 Free PMC article.
-
Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation.Mol Biol Cell. 2007 Nov;18(11):4648-58. doi: 10.1091/mbc.e07-06-0570. Epub 2007 Sep 12. Mol Biol Cell. 2007. PMID: 17855506 Free PMC article.
-
Tristetraprolin down-regulates IL-23 expression in colon cancer cells.Mol Cells. 2013 Dec;36(6):571-6. doi: 10.1007/s10059-013-0268-6. Epub 2013 Nov 29. Mol Cells. 2013. PMID: 24292977 Free PMC article.
-
The role of RNA-binding protein tristetraprolin in cancer and immunity.Med Oncol. 2017 Nov 9;34(12):196. doi: 10.1007/s12032-017-1055-6. Med Oncol. 2017. PMID: 29124478 Review.
Cited by
-
Roles of Tristetraprolin in Tumorigenesis.Int J Mol Sci. 2018 Oct 29;19(11):3384. doi: 10.3390/ijms19113384. Int J Mol Sci. 2018. PMID: 30380668 Free PMC article. Review.
-
Dysregulation of TTP and HuR plays an important role in cancers.Tumour Biol. 2016 Nov;37(11):14451-14461. doi: 10.1007/s13277-016-5397-z. Epub 2016 Sep 19. Tumour Biol. 2016. PMID: 27644249 Review.
-
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33.Sci Rep. 2016 Apr 14;6:24505. doi: 10.1038/srep24505. Sci Rep. 2016. PMID: 27074834 Free PMC article.
-
Tristetraprolin mediates radiation-induced TNF-α production in lung macrophages.PLoS One. 2013;8(2):e57290. doi: 10.1371/journal.pone.0057290. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23468959 Free PMC article.
-
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.Oncotarget. 2016 Dec 13;7(50):83462-83475. doi: 10.18632/oncotarget.13128. Oncotarget. 2016. PMID: 27825143 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources